HARROW HEALTH | INC. Corporate Presentation | August 2021 Safe Harbor 2 This presentation contains express "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and proje ...

Harrow Health, Inc. (NASDAQ:HROW) Q2 2021 Earnings Conference Call August 10, 2021 4:45 PM ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer Conference Call Participants Jeffrey Cohen - Ladenburg Thalmann Brooks O'Neil - Lake Street Capital Markets Andrew D'Silva - B. Riley FBR Operator Good afternoon, and welcome to Harrow Health's Second Quarter 2021 Earning Conference Call. My name is Ilie, and ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2021 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission File Number: 001-35814 Harrow Health, Inc. (Exact name of registrant as specified in its charter) Delaware 45-0567010 (State or ot ...

Harrow Health, Inc. (NASDAQ:HROW) Q1 2021 Earnings Conference Call May 11, 2021 4:45 PM ET Company Participants Jamie Webb - Director, Communications and IR Mark Baum - CEO Andrew Boll - CFO Conference Call Participants Andrew D'Silva - B. Riley Securities Operator Good afternoon, and welcome to the Harrow Health's First Quarter 2021 Earning Conference Call. My name is Carl, and I'll be your operator for today's call. At this time, all participants are in a listen-only mode. Later, we will conduct a questio ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2021 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission File Number: 001-35814 Harrow Health, Inc. (Exact name of registrant as specified in its charter) Delaware 45-0567010 (State or othe ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K (Mark One) ☒ ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-35814 HARROW HEALTH, INC. (Exact name of registrant as specified in its charter) Delaware 45-0567010 (State or other jurisdiction of ...

Harrow Health, Inc. (NASDAQ:HROW) Q3 2020 Earnings Conference Call November 9, 2020 4:45 PM ET Company Participants Mark Baum - CEO Andrew Boll - CFO Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Andrew D'Silva - B. Riley FBR Operator Good afternoon, and welcome to the conference call covering Harrow Health's Financial Results and Business Update for the Third Quarter 2020. On the call joining me today, I have Harrow's Chief Executive Officer, Mark L. Baum; and Harrow's Chief Fina ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, D.C. 20549 FORM 10-Q ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2020 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from ___________ to _____________ Commission File Number: 001-35814 Harrow Health, Inc. (Exact name of registrant as specified in its charter) Delaware 45-0567010 (State or ...

NASDAQ: HROW OUTSTANDING COMMON STOCK: 25.6M SHARES ESTIMATED MARKET CAPITALIZATION $167M PRICE PER SHARE as of July 7, 2020 $6.51 SEPTEMBER 2020 SAFE HARBOR This presentation contains express "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties ...

Harrow Health, Inc. (NASDAQ:HROW) Q2 2020 Earnings Conference Call August 10, 2020 5:00 PM ET Company Participants Mark Baum - Chief Executive Officer Andrew Boll - Chief Financial Officer Conference Call Participants Brooks O'Neil - Lake Street Capital Markets Andrew D'Silva - B. Riley FBR Greg Kitt - Pinnacle Family Office Operator Good afternoon, and welcome to the conference call covering Harrow Health's Financial Results and Business Update for the Second Quarter of 2020. On the call joining me today, ...